NICKOLAS RONGEY: Open Payments
NPI 1982160990 · BRIDGETON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 64 payments from 12 companies in 2025. Trend: 2023 $1,158 · 2024 $1,265 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $349 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| Novo Nordisk Inc | 6 | $118 |
| PFIZER INC. | 4 | $94 |
| Amgen Inc. | 5 | $86 |
| Kestra Medical Technology Services, Inc. | 2 | $86 |
| CVRx, Inc. | 1 | $81 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Esperion Therapeutics, Inc. | 1 | $29 |
Products named: LEQVIO, Kerendia, ELIQUIS, FARXIGA, REPATHA, Assure WCD, Barostim Neo System, Wegovy.
Industry payments across MO — which companies pay providers there.
